Pyrukynd الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

pyrukynd

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Methylphenidate STADA Hart hylki með breyttan losunarhraða 30 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 30 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg

Methylphenidate STADA Hart hylki með breyttan losunarhraða 20 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 20 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð; methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg

Medikinet CR (Medikinet retard) Hart hylki með breyttan losunarhraða 30 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

medikinet cr (medikinet retard) hart hylki með breyttan losunarhraða 30 mg

medice arzneimittel pütter gmbh & co. kg* - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 30 mg